NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE was reported 3223 times

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BILOMA RUPTURE 1 1.0000
1 SQUAMOUS CELL CARCINOMA OF THE VAGINA 2 0.0408
2 AMNIOTIC MEMBRANE GRAFT 1 0.0385
3 ATYPICAL MIGRAINE 1 0.0217
4 DECIDUAL CAST 1 0.0200
5 CHOLANGIOLITIS 1 0.0169
6 ALCOHOLIC HANGOVER 1 0.0164
7 CHEST CRUSHING 1 0.0156
8 CONTACT LENS INTOLERANCE 2 0.0127
9 AMENORRHOEA 220 0.0125
10 ADMINISTRATION SITE WARMTH 1 0.0122
11 AEROPHAGIA 2 0.0115
12 HYPOMENORRHOEA 31 0.0113
13 CERVICAL DISCHARGE 1 0.0109
14 COMPUTERISED TOMOGRAM HEAD ABNORMAL 1 0.0101
15 PREMENSTRUAL DYSPHORIC DISORDER 2 0.0099
16 OVULATION PAIN 2 0.0095
17 SEASONAL AFFECTIVE DISORDER 3 0.0095
18 METRORRHAGIA 156 0.0091
19 ASTHMA EXERCISE INDUCED 3 0.0086
20 CHLOASMA 4 0.0086
21 DRUG NAME CONFUSION 1 0.0079
22 INTESTINAL MALROTATION 2 0.0076
23 VAGINAL ABSCESS 2 0.0074
24 INTERMENSTRUAL BLEEDING 38 0.0068
25 DIAGNOSTIC PROCEDURE 1 0.0066
26 CRYSTAL URINE 1 0.0063
27 COSTOVERTEBRAL ANGLE TENDERNESS 1 0.0061
28 PREGNANCY ON ORAL CONTRACEPTIVE 16 0.0061
29 CENTRAL NERVOUS SYSTEM INFLAMMATION 2 0.0060
30 HEPATIC ADENOMA 3 0.0058
31 BLOOD COPPER INCREASED 1 0.0056
32 BASILAR ARTERY THROMBOSIS 1 0.0056
33 POLYCYSTIC OVARIAN SYNDROME 2 0.0052
34 BREAST OEDEMA 1 0.0052
35 ADULTERATED PRODUCT 1 0.0050
36 HIGH FREQUENCY ABLATION 2 0.0049
37 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 2 0.0048
38 INTERNAL INJURY 3 0.0046
39 CHOLELITHOTOMY 1 0.0046
40 INFUSION SITE SCAR 2 0.0045
41 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
42 MATERNAL EXPOSURE TIMING UNSPECIFIED 16 0.0043
43 MENORRHAGIA 80 0.0041
44 MENSTRUATION IRREGULAR 108 0.0040
45 DEVICE ALLERGY 1 0.0040
46 BLOOD CORTISOL INCREASED 1 0.0038
47 MEDICAL DEVICE PAIN 8 0.0037
48 ANTITHROMBIN III DECREASED 1 0.0037
49 BURNS FIRST DEGREE 1 0.0035
50 ENAMEL ANOMALY 1 0.0035
51 AVERSION 1 0.0035
52 DYSMENORRHOEA 46 0.0035
53 CHANGE IN SUSTAINED ATTENTION 1 0.0033
54 BREAST INFLAMMATION 1 0.0032
55 COITAL BLEEDING 5 0.0032
56 OLIGOMENORRHOEA 7 0.0032
57 MENSTRUAL DISORDER 26 0.0031
58 PARTNER STRESS 3 0.0031
59 HEAVY MENSTRUAL BLEEDING 27 0.0030
60 ACNE CYSTIC 9 0.0030
61 TRIPLE NEGATIVE BREAST CANCER 2 0.0030
62 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 4 0.0030
63 PELVIC FLUID COLLECTION 2 0.0028
64 ENDOMETRIAL ABLATION 1 0.0028
65 PREGNANCY ON CONTRACEPTIVE 4 0.0027
66 PRE-EXISTING CONDITION IMPROVED 17 0.0027
67 MENSTRUATION DELAYED 29 0.0027
68 SUPPRESSED LACTATION 2 0.0027
69 POLYMENORRHOEA 9 0.0026
70 POLYCYSTIC OVARIES 4 0.0026
71 CONVULSIVE THRESHOLD LOWERED 1 0.0025
72 PROCEDURAL NAUSEA 2 0.0025
73 UTERINE PERFORATION 21 0.0025
74 DEVICE COLOUR ISSUE 1 0.0025
75 VACCINATION COMPLICATION 2 0.0024
76 BREAST ENLARGEMENT 8 0.0024
77 COVID-19 IMMUNISATION 2 0.0024
78 BREAST TENDERNESS 18 0.0024
79 COELIAC DISEASE 23 0.0023
80 ABNORMAL UTERINE BLEEDING 6 0.0023
81 HORMONE LEVEL ABNORMAL 11 0.0023
82 UTERINE DILATION AND CURETTAGE 2 0.0022
83 MIGRAINE WITH AURA 6 0.0022
84 ALLERGY TO ARTHROPOD STING 1 0.0022
85 UTERINE SPASM 4 0.0022
86 ABNORMAL WITHDRAWAL BLEEDING 2 0.0022
87 CATAPLEXY 3 0.0021
88 PRODUCT AFTER TASTE 2 0.0021
89 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
90 SLEEP PARALYSIS 3 0.0020
91 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
92 BLEPHARAL PIGMENTATION 1 0.0020
93 NIPPLE PAIN 4 0.0020
94 BREAST CONSERVING SURGERY 1 0.0020
95 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 4 0.0019
96 PRODUCT BLISTER PACKAGING ISSUE 2 0.0019
97 CYST REMOVAL 1 0.0019
98 UTERINE HAEMORRHAGE 8 0.0019
99 INTRACRANIAL VENOUS SINUS THROMBOSIS 2 0.0019
100 CYSTITIS INTERSTITIAL 3 0.0019
101 BINGE EATING 2 0.0019
102 EPHELIDES 1 0.0019
103 BODY FAT DISORDER 1 0.0018
104 COSTOCHONDRITIS 3 0.0018
105 PRODUCT NAME CONFUSION 2 0.0018
106 DRUG EFFECT PROLONGED 1 0.0018
107 ENDOMETRIAL THICKENING 1 0.0018
108 STRESS AT WORK 2 0.0018
109 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
110 INTRUSIVE THOUGHTS 2 0.0017
111 ENDOSCOPY 1 0.0017
112 DYSFUNCTIONAL UTERINE BLEEDING 2 0.0016
113 MEDICAL DEVICE DISCOMFORT 5 0.0016
114 CORTISOL INCREASED 1 0.0016
115 BLOOD IRON INCREASED 3 0.0016
116 BENIGN INTRACRANIAL HYPERTENSION 2 0.0016
117 ADNEXA UTERI PAIN 2 0.0016
118 OVARIAN CYST RUPTURED 2 0.0016
119 DRUG TITRATION ERROR 4 0.0015
120 VULVOVAGINAL DRYNESS 5 0.0015
121 NASAL SEPTUM DEVIATION 3 0.0015
122 BRONCHITIS VIRAL 1 0.0015
123 MATERNAL EXPOSURE DURING BREAST FEEDING 6 0.0015
124 PREMENSTRUAL SYNDROME 2 0.0015
125 ANGULAR CHEILITIS 1 0.0014
126 TRICHORRHEXIS 4 0.0014
127 THERAPEUTIC PROCEDURE 2 0.0014
128 APPLICATION SITE ULCER 1 0.0014
129 BORDERLINE PERSONALITY DISORDER 1 0.0014
130 OVARIAN CYST 14 0.0014
131 HAEMORRHAGE IN PREGNANCY 2 0.0014
132 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
133 PREGNANCY 27 0.0013
134 GASTROSTOMY 2 0.0013
135 SUBSTANCE USE 2 0.0013
136 BACTERIAL VAGINOSIS 2 0.0013
137 SKIN TIGHTNESS 6 0.0013
138 CROUP INFECTIOUS 1 0.0013
139 VAGINAL HAEMORRHAGE 55 0.0013
140 VOLVULUS 3 0.0013
141 BREAST CALCIFICATIONS 1 0.0013
142 VULVOVAGINAL PAIN 6 0.0012
143 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
144 INTERCEPTED PRODUCT DISPENSING ERROR 2 0.0012
145 HIGH DENSITY LIPOPROTEIN DECREASED 4 0.0012
146 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
147 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
148 VULVOVAGINAL PRURITUS 6 0.0012
149 TYMPANIC MEMBRANE PERFORATION 2 0.0012
150 PRODUCT DOSE OMISSION 77 0.0012
151 FOOD AVERSION 2 0.0012
152 DEVICE LOOSENING 1 0.0012
153 THYROIDECTOMY 2 0.0012
154 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
155 AFFECTIVE DISORDER 9 0.0011
156 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
157 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
158 DRUG DETOXIFICATION 1 0.0011
159 DEVICE PLACEMENT ISSUE 4 0.0011
160 BREAST SWELLING 3 0.0011
161 PELVIC PAIN 20 0.0011
162 VULVOVAGINAL SWELLING 2 0.0011
163 UTERINE LEIOMYOMA 8 0.0011
164 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
165 GENITAL HAEMORRHAGE 14 0.0011
166 RED BLOOD CELL COUNT INCREASED 3 0.0011
167 HYPERTRICHOSIS 2 0.0011
168 LYMPH NODE PAIN 2 0.0011
169 IMPULSIVE BEHAVIOUR 4 0.0011
170 PARANASAL SINUS DISCOMFORT 4 0.0011
171 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
172 APPLICATION SITE BRUISE 1 0.0010
173 BLOOD IRON ABNORMAL 1 0.0010
174 DUST ALLERGY 1 0.0010
175 EMBEDDED DEVICE 10 0.0010
176 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
177 MOOD SWINGS 32 0.0010
178 VAGINAL DISCHARGE 10 0.0010
179 BUTTERFLY RASH 1 0.0010
180 BENIGN BREAST NEOPLASM 1 0.0010
181 PRODUCT COLOUR ISSUE 5 0.0010
182 DEMYELINATING POLYNEUROPATHY 1 0.0010
183 CORONAVIRUS TEST POSITIVE 1 0.0010
184 BODY TEMPERATURE FLUCTUATION 2 0.0010
185 BLOOD SODIUM ABNORMAL 1 0.0009
186 BREAST PAIN 10 0.0009
187 ABSCESS INTESTINAL 2 0.0009
188 BRUXISM 5 0.0009
189 INFUSION SITE BRUISING 2 0.0009
190 SOMNAMBULISM 6 0.0009
191 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
192 SPINAL COLUMN INJURY 2 0.0009
193 POST-TRAUMATIC STRESS DISORDER 6 0.0009
194 PLANTAR FASCIITIS 3 0.0009
195 THERAPEUTIC RESPONSE UNEXPECTED 40 0.0009
196 DYSPAREUNIA 4 0.0009
197 ADMINISTRATION SITE PAIN 1 0.0009
198 HYPOPNOEA 3 0.0009
199 BLADDER OPERATION 1 0.0009
200 UTERINE DISORDER 2 0.0009
201 ALLODYNIA 1 0.0009
202 ORAL SURGERY 2 0.0009
203 HANGOVER 3 0.0009
204 ENDOMETRIOSIS 4 0.0008
205 EMBOLISM ARTERIAL 1 0.0008
206 DIABETES INSIPIDUS 2 0.0008
207 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
208 VULVOVAGINAL BURNING SENSATION 5 0.0008
209 BLADDER PROLAPSE 1 0.0008
210 SENSITIVE SKIN 6 0.0008
211 AMYLASE INCREASED 3 0.0008
212 HYPOPHOSPHATAEMIA 6 0.0008
213 MOOD ALTERED 22 0.0008
214 ALLERGY TO CHEMICALS 1 0.0008
215 SNORING 3 0.0008
216 ENDOCRINE DISORDER 1 0.0008
217 PROCEDURAL HAEMORRHAGE 3 0.0008
218 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
219 DEVICE MISUSE 1 0.0008
220 RENAL CYST 6 0.0008
221 ENURESIS 3 0.0007
222 SKIN DISCOMFORT 2 0.0007
223 INTENTIONAL DOSE OMISSION 21 0.0007
224 CLUMSINESS 2 0.0007
225 CORNEAL ABRASION 1 0.0007
226 ONYCHOCLASIS 5 0.0007
227 EOSINOPHILIC OESOPHAGITIS 2 0.0007
228 DISCHARGE 1 0.0007
229 COMPLICATION OF DEVICE REMOVAL 13 0.0007
230 CHRONIC FATIGUE SYNDROME 1 0.0007
231 CEREBRAL THROMBOSIS 2 0.0007
232 CONNECTIVE TISSUE DISORDER 1 0.0007
233 VITAMIN D DECREASED 6 0.0007
234 PANIC ATTACK 25 0.0007
235 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
236 FOREIGN BODY IN REPRODUCTIVE TRACT 6 0.0007
237 BRAIN HERNIATION 2 0.0007
238 EPICONDYLITIS 1 0.0007
239 ASTIGMATISM 1 0.0007
240 COMPLICATION OF DEVICE INSERTION 13 0.0007
241 MIGRAINE 62 0.0006
242 FOOD ALLERGY 5 0.0006
243 ROSACEA 3 0.0006
244 VAGINAL INFECTION 3 0.0006
245 RESPIRATORY RATE DECREASED 2 0.0006
246 THERAPEUTIC RESPONSE CHANGED 4 0.0006
247 INCORRECT DISPOSAL OF PRODUCT 2 0.0006
248 AUTOIMMUNE DISORDER 6 0.0006
249 INFUSION SITE HAEMORRHAGE 2 0.0006
250 OTITIS MEDIA 2 0.0006
251 ABDOMINAL TENDERNESS 3 0.0006
252 APPETITE DISORDER 4 0.0006
253 EDUCATIONAL PROBLEM 1 0.0006
254 ACNE 45 0.0006
255 DRUG TOLERANCE 3 0.0006
256 BILIARY DYSKINESIA 1 0.0006
257 DEAFNESS BILATERAL 1 0.0006
258 ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE 1 0.0006
259 INITIAL INSOMNIA 6 0.0006
260 BLOOD CHLORIDE INCREASED 1 0.0006
261 TACHYPHRENIA 2 0.0006
262 HYSTERECTOMY 5 0.0006
263 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 104 0.0006
264 BREAST DISCHARGE 1 0.0006
265 BURNS SECOND DEGREE 1 0.0006
266 ALOPECIA AREATA 1 0.0006
267 HEART DISEASE CONGENITAL 2 0.0006
268 SEASONAL ALLERGY 8 0.0006
269 BREAST CYST 1 0.0006
270 ANAL FISTULA 3 0.0006
271 IMPAIRED QUALITY OF LIFE 8 0.0006
272 LOSS OF LIBIDO 5 0.0006
273 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
274 MONOCYTE COUNT INCREASED 2 0.0006
275 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
276 INFUSION SITE PAIN 7 0.0005
277 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
278 DENTAL CARE 1 0.0005
279 ABORTION INCOMPLETE 1 0.0005
280 DEPRESSION 121 0.0005
281 DERMATITIS CONTACT 6 0.0005
282 CHOLECYSTECTOMY 6 0.0005
283 SLEEP APNOEA SYNDROME 10 0.0005
284 CRYING 19 0.0005
285 PRODUCT TASTE ABNORMAL 7 0.0005
286 ANXIETY 147 0.0005
287 PANIC DISORDER 2 0.0005
288 CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0005
289 IMPAIRED GASTRIC EMPTYING 7 0.0005
290 CERVIX CARCINOMA 2 0.0005
291 KNEE OPERATION 5 0.0005
292 SINUS HEADACHE 3 0.0005
293 NASAL DISCOMFORT 4 0.0005
294 EXPOSURE VIA BREAST MILK 2 0.0005
295 SYMPTOM RECURRENCE 3 0.0005
296 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
297 INTRACRANIAL ANEURYSM 2 0.0005
298 EAR DISCOMFORT 5 0.0005
299 COMPULSIVE SHOPPING 1 0.0005
300 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
301 SCOLIOSIS 3 0.0005
302 EXPIRED PRODUCT ADMINISTERED 16 0.0005
303 SWELLING OF EYELID 3 0.0005
304 SURGERY 28 0.0005
305 DEEP VEIN THROMBOSIS 31 0.0005
306 DEVICE MATERIAL ISSUE 1 0.0005
307 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
308 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
309 ALCOHOLISM 2 0.0005
310 TENSION HEADACHE 2 0.0005
311 DEREALISATION 1 0.0005
312 INCOHERENT 3 0.0005
313 PULMONARY EMBOLISM 44 0.0005
314 SKIN SWELLING 4 0.0005
315 SINUSITIS 47 0.0005
316 CERVICAL DYSPLASIA 1 0.0005
317 INSURANCE ISSUE 7 0.0005
318 TONGUE DISCOLOURATION 2 0.0005
319 CLOSTRIDIUM TEST POSITIVE 1 0.0005
320 BRAIN FOG 7 0.0004
321 PREGNANCY WITH CONTRACEPTIVE DEVICE 4 0.0004
322 VASCULAR DEVICE INFECTION 2 0.0004
323 OPTIC NEURITIS 4 0.0004
324 URINE ABNORMALITY 2 0.0004
325 DEVICE DISLOCATION 19 0.0004
326 HUNGER 6 0.0004
327 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
328 DEFAECATION URGENCY 3 0.0004
329 YELLOW SKIN 2 0.0004
330 INJURY 30 0.0004
331 FLANK PAIN 4 0.0004
332 SUICIDAL IDEATION 39 0.0004
333 OFF LABEL USE 373 0.0004
334 BLOOD PROLACTIN INCREASED 2 0.0004
335 SPUTUM DISCOLOURED 4 0.0004
336 FEELING JITTERY 8 0.0004
337 AFFECT LABILITY 4 0.0004
338 NOCTURIA 5 0.0004
339 APATHY 6 0.0004
340 MAJOR DEPRESSION 3 0.0004
341 SCAR 7 0.0004
342 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
343 SINUS DISORDER 8 0.0004
344 FEELING DRUNK 3 0.0004
345 DEVICE INFUSION ISSUE 1 0.0004
346 INJECTION SITE INFLAMMATION 2 0.0004
347 APPLICATION SITE SWELLING 2 0.0004
348 PROTEIN URINE PRESENT 2 0.0004
349 VEIN DISORDER 2 0.0004
350 PRODUCT ADMINISTRATION ERROR 8 0.0004
351 ABDOMINAL PAIN LOWER 10 0.0004
352 ENDODONTIC PROCEDURE 1 0.0004
353 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 28 0.0004
354 APPENDICITIS PERFORATED 1 0.0004
355 ABDOMINAL DISTENSION 41 0.0004
356 SLUGGISHNESS 4 0.0004
357 WEIGHT LOSS POOR 2 0.0004
358 EUPHORIC MOOD 4 0.0004
359 PRODUCT STORAGE ERROR 34 0.0004
360 APHTHOUS ULCER 3 0.0004
361 MALABSORPTION 2 0.0004
362 IRRITABILITY 23 0.0004
363 PRODUCT SUBSTITUTION ISSUE 22 0.0004
364 FOOD CRAVING 2 0.0004
365 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
366 PRODUCT PRESCRIBING ERROR 9 0.0004
367 GINGIVAL PAIN 3 0.0004
368 OBESITY 6 0.0004
369 BLOOD POTASSIUM ABNORMAL 1 0.0004
370 ALCOHOL ABUSE 1 0.0004
371 MUSCLE SPASMS 68 0.0004
372 FIBROMYALGIA 9 0.0004
373 UNEVALUABLE EVENT 28 0.0004
374 CHEILITIS 2 0.0004
375 ERYTHEMA OF EYELID 2 0.0004
376 EAR CONGESTION 1 0.0004
377 HYPERAESTHESIA 3 0.0004
378 HAIR DISORDER 3 0.0004
379 PRODUCT DOSE OMISSION ISSUE 107 0.0004
380 GASTROINTESTINAL PAIN 4 0.0004
381 DRUG DOSE OMISSION 60 0.0004
382 DEAFNESS UNILATERAL 2 0.0004
383 INJECTION SITE INJURY 2 0.0004
384 CHOLECYSTITIS INFECTIVE 1 0.0004
385 STREPTOCOCCAL INFECTION 2 0.0004
386 DEPRESSED MOOD 19 0.0004
387 ELECTRIC SHOCK SENSATION 1 0.0004
388 WEIGHT INCREASED 79 0.0004
389 PARANOIA 6 0.0003
390 METABOLIC DISORDER 2 0.0003
391 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
392 ABORTION 1 0.0003
393 GASTROENTERITIS 5 0.0003
394 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
395 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
396 THIRST 6 0.0003
397 GASTROINTESTINAL INFECTION 3 0.0003
398 ATYPICAL PNEUMONIA 1 0.0003
399 GASTROENTERITIS VIRAL 6 0.0003
400 CENTRAL VENOUS CATHETERISATION 1 0.0003
401 CRANIOCEREBRAL INJURY 1 0.0003
402 RESTLESS LEGS SYNDROME 6 0.0003
403 EMERGENCY CARE 1 0.0003
404 EMBOLISM VENOUS 1 0.0003
405 PRESYNCOPE 8 0.0003
406 IMPAIRED WORK ABILITY 7 0.0003
407 DYSAESTHESIA 1 0.0003
408 MENISCUS INJURY 2 0.0003
409 ECTOPIC PREGNANCY 1 0.0003
410 POOR QUALITY SLEEP 7 0.0003
411 ECZEMA 17 0.0003
412 PROCEDURAL PAIN 9 0.0003
413 DIASTOLIC DYSFUNCTION 1 0.0003
414 MUSCULOSKELETAL CHEST PAIN 5 0.0003
415 DEVICE BREAKAGE 13 0.0003
416 SECRETION DISCHARGE 4 0.0003
417 NASAL DRYNESS 2 0.0003
418 NIGHTMARE 11 0.0003
419 INFUSION SITE SWELLING 2 0.0003
420 MUSCLE ATROPHY 4 0.0003
421 PRODUCT PACKAGING ISSUE 3 0.0003
422 BILE DUCT STONE 1 0.0003
423 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
424 DRUG PRESCRIBING ERROR 6 0.0003
425 NIGHT SWEATS 10 0.0003
426 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
427 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
428 VITAMIN D DEFICIENCY 3 0.0003
429 ORAL HERPES 6 0.0003
430 PHARYNGEAL SWELLING 3 0.0003
431 BRADYPHRENIA 2 0.0003
432 ANHEDONIA 8 0.0003
433 INCORRECT PRODUCT STORAGE 4 0.0003
434 URINARY INCONTINENCE 9 0.0003
435 IMMUNE SYSTEM DISORDER 4 0.0003
436 LIGAMENT SPRAIN 3 0.0003
437 PRODUCT FORMULATION ISSUE 2 0.0003
438 CORONAVIRUS INFECTION 2 0.0003
439 DRY EYE 15 0.0003
440 QUALITY OF LIFE DECREASED 4 0.0003
441 BREAST MASS 2 0.0003
442 PRODUCT PHYSICAL ISSUE 6 0.0003
443 INTENTIONAL SELF-INJURY 6 0.0003
444 WRONG PRODUCT ADMINISTERED 2 0.0003
445 ANGER 10 0.0003
446 DRY THROAT 3 0.0003
447 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
448 DEPRESSION SUICIDAL 1 0.0003
449 FEELING ABNORMAL 69 0.0003
450 TENDERNESS 3 0.0003
451 UNINTENDED PREGNANCY 3 0.0003
452 HAEMORRHAGE 30 0.0003
453 WEIGHT FLUCTUATION 3 0.0003
454 RASH MACULAR 10 0.0003
455 EAR PRURITUS 1 0.0003
456 EMBOLIC STROKE 1 0.0003
457 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
458 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
459 APPENDICECTOMY 1 0.0003
460 IRRITABLE BOWEL SYNDROME 6 0.0003
461 PARALYSIS 4 0.0003
462 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
463 VERTIGO 17 0.0003
464 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
465 TOOTHACHE 5 0.0003
466 MENTAL DISORDER 12 0.0003
467 PRODUCT PRESCRIBING ISSUE 6 0.0003
468 ABORTION SPONTANEOUS 11 0.0003
469 DEVICE KINK 1 0.0003
470 ABDOMINAL PAIN 63 0.0003
471 FUNGAL INFECTION 9 0.0003
472 ARTHROPOD BITE 2 0.0003
473 THINKING ABNORMAL 5 0.0003
474 IMMUNODEFICIENCY 4 0.0003
475 SUNBURN 2 0.0003
476 EYE PRURITUS 9 0.0003
477 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
478 CHRONIC SINUSITIS 1 0.0003
479 HYPOAESTHESIA ORAL 4 0.0003
480 PAROSMIA 2 0.0003
481 ALOPECIA 52 0.0003
482 EAR INFECTION 7 0.0003
483 THROMBOSIS 21 0.0003
484 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
485 HEADACHE 163 0.0003
486 EMOTIONAL DISORDER 8 0.0003
487 CONCUSSION 2 0.0003
488 PRODUCT USE ISSUE 48 0.0003
489 NAUSEA 200 0.0003
490 DISEASE RECURRENCE 12 0.0003
491 BLOOD ALBUMIN DECREASED 2 0.0003
492 CHOLECYSTITIS 3 0.0003
493 ACCIDENT 3 0.0003
494 BLEPHARITIS 1 0.0002
495 PALPITATIONS 29 0.0002
496 CHOLELITHIASIS 8 0.0002
497 HICCUPS 2 0.0002
498 MANIA 4 0.0002
499 APPLICATION SITE EXFOLIATION 1 0.0002
500 BLOOD PRESSURE INCREASED 37 0.0002
501 CYST 3 0.0002
502 DISTURBANCE IN ATTENTION 13 0.0002
503 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
504 HYPOAESTHESIA 36 0.0002
505 ROAD TRAFFIC ACCIDENT 10 0.0002
506 URTICARIA 40 0.0002
507 INFUSION SITE ERYTHEMA 2 0.0002
508 INJECTION SITE IRRITATION 3 0.0002
509 DRY MOUTH 19 0.0002
510 MYDRIASIS 3 0.0002
511 COVID-19 41 0.0002
512 PSYCHOLOGICAL TRAUMA 2 0.0002
513 MUSCLE STRAIN 2 0.0002
514 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
515 INJECTION SITE RASH 7 0.0002
516 ANKYLOSING SPONDYLITIS 3 0.0002
517 DERMATITIS ATOPIC 12 0.0002
518 SARS-COV-2 TEST POSITIVE 3 0.0002
519 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 46 0.0002
520 COLD SWEAT 4 0.0002
521 LYMPHADENOPATHY 8 0.0002
522 EXPOSURE DURING PREGNANCY 14 0.0002
523 HAIR TEXTURE ABNORMAL 3 0.0002
524 FACIAL PAIN 2 0.0002
525 RASH PAPULAR 5 0.0002
526 FEAR 6 0.0002
527 EMOTIONAL DISTRESS 27 0.0002
528 ANAL INCONTINENCE 2 0.0002
529 SINUS CONGESTION 3 0.0002
530 INJECTION SITE SWELLING 17 0.0002
531 OROPHARYNGEAL DISCOMFORT 2 0.0002
532 NASAL CONGESTION 13 0.0002
533 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
534 AGGRESSION 11 0.0002
535 HIDRADENITIS 2 0.0002
536 HYPOTHYROIDISM 7 0.0002
537 INFLUENZA LIKE ILLNESS 18 0.0002
538 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
539 INJECTION SITE REACTION 15 0.0002
540 SKIN DISCOLOURATION 10 0.0002
541 RETINAL DETACHMENT 2 0.0002
542 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
543 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
544 PRODUCT DISTRIBUTION ISSUE 2 0.0002
545 COORDINATION ABNORMAL 3 0.0002
546 WITHDRAWAL SYNDROME 9 0.0002
547 CARPAL TUNNEL SYNDROME 3 0.0002
548 ABORTION INDUCED 2 0.0002
549 DEVICE ISSUE 19 0.0002
550 LIP SWELLING 7 0.0002
551 DIZZINESS 104 0.0002
552 PARAESTHESIA ORAL 3 0.0002
553 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
554 NEURALGIA 5 0.0002
555 HAEMORRHOIDS 4 0.0002
556 HYPERSENSITIVITY 38 0.0002
557 INFLAMMATORY BOWEL DISEASE 2 0.0002
558 ABDOMINAL PAIN UPPER 42 0.0002
559 ILLNESS 21 0.0002
560 INJECTION SITE URTICARIA 5 0.0002
561 DISORIENTATION 8 0.0002
562 HEART RATE INCREASED 20 0.0002
563 SKIN EXFOLIATION 17 0.0002
564 BLADDER DISORDER 2 0.0002
565 COLON CANCER 3 0.0002
566 BLOOD PRESSURE ABNORMAL 4 0.0002
567 BRAIN INJURY 2 0.0002
568 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
569 EXTRA DOSE ADMINISTERED 8 0.0002
570 FEEDING DISORDER 4 0.0002
571 DEVICE FAILURE 3 0.0002
572 MOTOR DYSFUNCTION 2 0.0002
573 NEUTROPHIL COUNT INCREASED 2 0.0002
574 EYE PAIN 11 0.0002
575 TEMPERATURE INTOLERANCE 2 0.0002
576 INFLAMMATION 10 0.0002
577 INSOMNIA 51 0.0002
578 PRODUCT ODOUR ABNORMAL 2 0.0002
579 DERMATITIS 4 0.0002
580 MULTIPLE SCLEROSIS RELAPSE 13 0.0002
581 HEAD INJURY 6 0.0002
582 INCONTINENCE 2 0.0002
583 PNEUMOTHORAX 3 0.0002
584 PREMATURE DELIVERY 3 0.0002
585 INJECTION SITE BRUISING 15 0.0002
586 RETCHING 4 0.0002
587 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
588 JOINT INJURY 4 0.0002
589 CONTUSION 18 0.0002
590 ANAL FISSURE 1 0.0002
591 HEREDITARY ANGIOEDEMA 2 0.0002
592 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
593 PAIN OF SKIN 5 0.0002
594 MUSCLE TIGHTNESS 3 0.0002
595 BEHAVIOUR DISORDER 1 0.0002
596 PHARYNGITIS STREPTOCOCCAL 2 0.0002
597 BACK DISORDER 3 0.0002
598 SWELLING FACE 12 0.0002
599 PRODUCT QUALITY ISSUE 25 0.0002
600 BIPOLAR DISORDER 2 0.0002
601 BACK INJURY 2 0.0002
602 TREATMENT NONCOMPLIANCE 10 0.0002
603 ASTHENOPIA 1 0.0002
604 PHOTOSENSITIVITY REACTION 3 0.0002
605 AUTISM SPECTRUM DISORDER 1 0.0002
606 APPLICATION SITE PAIN 4 0.0002
607 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
608 ABNORMAL DREAMS 5 0.0002
609 DENTAL CARIES 2 0.0002
610 CYSTIC FIBROSIS 1 0.0002
611 FEELING HOT 11 0.0002
612 MALNUTRITION 2 0.0002
613 FATIGUE 139 0.0002
614 SKIN INFECTION 2 0.0002
615 OCULAR DISCOMFORT 2 0.0002
616 CHOLECYSTITIS ACUTE 1 0.0002
617 SCAB 2 0.0002
618 INCORRECT DOSE ADMINISTERED 40 0.0002
619 SKIN IRRITATION 8 0.0002
620 NEPHROLITHIASIS 8 0.0002
621 NEOPLASM 2 0.0002
622 SEIZURE 20 0.0002
623 ORTHOSTATIC HYPOTENSION 3 0.0002
624 DEVICE USE ISSUE 3 0.0002
625 SEXUAL DYSFUNCTION 2 0.0002
626 PSYCHOTIC DISORDER 5 0.0002
627 BLOOD IRON DECREASED 2 0.0002
628 GALLBLADDER DISORDER 3 0.0002
629 THERAPY INTERRUPTED 12 0.0002
630 PARAESTHESIA 26 0.0002
631 INJECTION SITE PRURITUS 11 0.0002
632 DRUG ADMINISTRATION ERROR 5 0.0002
633 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
634 SMALL INTESTINAL OBSTRUCTION 2 0.0002
635 BRONCHITIS 12 0.0002
636 OROPHARYNGEAL PAIN 15 0.0002
637 BALANCE DISORDER 14 0.0002
638 LIMB DISCOMFORT 5 0.0002
639 PRODUCT USE IN UNAPPROVED INDICATION 40 0.0002
640 CHOLANGITIS 1 0.0002
641 EYE SWELLING 6 0.0002
642 HEPATIC STEATOSIS 3 0.0002
643 HAIR COLOUR CHANGES 2 0.0002
644 MIDDLE INSOMNIA 3 0.0002
645 VISION BLURRED 22 0.0002
646 INJECTION SITE DISCOLOURATION 2 0.0002
647 INTENTIONAL PRODUCT MISUSE 14 0.0002
648 PHOTOPHOBIA 3 0.0002
649 DYSARTHRIA 6 0.0002
650 PRURITUS 61 0.0002
651 PRODUCT COMPLAINT 4 0.0002
652 FLUSHING 16 0.0002
653 FLUID RETENTION 8 0.0002
654 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
655 COLITIS ULCERATIVE 7 0.0002
656 PAIN 96 0.0002
657 RASH 68 0.0002
658 ABDOMINAL DISCOMFORT 26 0.0002
659 EXPOSURE VIA SKIN CONTACT 4 0.0002
660 EAR PAIN 3 0.0002
661 INJECTION SITE INDURATION 2 0.0002
662 SOMNOLENCE 31 0.0002
663 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
664 SKIN BURNING SENSATION 11 0.0002
665 SKIN FISSURES 3 0.0002
666 PLATELET COUNT INCREASED 2 0.0002
667 NODULE 2 0.0002
668 MEMORY IMPAIRMENT 21 0.0002
669 ORAL CANDIDIASIS 2 0.0002
670 TOOTH INFECTION 2 0.0002
671 DISABILITY 3 0.0002
672 STAPHYLOCOCCAL INFECTION 5 0.0002
673 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
674 ABNORMAL BEHAVIOUR 6 0.0002
675 ADVERSE REACTION 2 0.0002
676 SKIN DISORDER 5 0.0001
677 EYE HAEMORRHAGE 2 0.0001
678 SWELLING 14 0.0001
679 VOMITING 70 0.0001
680 BRONCHIECTASIS 1 0.0001
681 DYSGEUSIA 11 0.0001
682 THROAT TIGHTNESS 4 0.0001
683 DISCOMFORT 9 0.0001
684 LIMB INJURY 4 0.0001
685 BODY TEMPERATURE INCREASED 3 0.0001
686 ABNORMAL LOSS OF WEIGHT 1 0.0001
687 AKATHISIA 2 0.0001
688 GINGIVAL BLEEDING 2 0.0001
689 RASH ERYTHEMATOUS 7 0.0001
690 DEVICE MECHANICAL ISSUE 2 0.0001
691 PERIPHERAL COLDNESS 2 0.0001
692 APHONIA 2 0.0001
693 WOUND 4 0.0001
694 HEART RATE DECREASED 5 0.0001
695 MOUTH ULCERATION 3 0.0001
696 SKIN REACTION 2 0.0001
697 SLEEP DISORDER 10 0.0001
698 CONDITION AGGRAVATED 43 0.0001
699 DIVERTICULUM 1 0.0001
700 LIVER FUNCTION TEST INCREASED 3 0.0001
701 HYPERSOMNIA 4 0.0001
702 EYE IRRITATION 8 0.0001
703 DEVICE EXPULSION 9 0.0001
704 PRURITUS GENERALISED 3 0.0001
705 INFECTION 20 0.0001
706 ANOSMIA 2 0.0001
707 HYPERTHYROIDISM 2 0.0001
708 PRODUCT DISPENSING ERROR 3 0.0001
709 BACK PAIN 32 0.0001
710 DRUG EFFECT INCOMPLETE 5 0.0001
711 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
712 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
713 DYSSTASIA 4 0.0001
714 DYSPHONIA 8 0.0001
715 WEIGHT DECREASED 38 0.0001
716 BLINDNESS TRANSIENT 1 0.0001
717 BLOOD PRESSURE DECREASED 9 0.0001
718 INJECTION SITE MASS 5 0.0001
719 TACHYCARDIA 12 0.0001
720 APHASIA 4 0.0001
721 LACRIMATION INCREASED 4 0.0001
722 APPLICATION SITE PRURITUS 3 0.0001
723 HYPERHIDROSIS 17 0.0001
724 PRODUCT AVAILABILITY ISSUE 3 0.0001
725 DRUG DISPENSING ERROR 2 0.0001
726 DISSOCIATION 1 0.0001
727 NASOPHARYNGITIS 24 0.0001
728 PSORIASIS 17 0.0001
729 CHEST PAIN 24 0.0001
730 DELUSION 2 0.0001
731 BLOOD CHOLESTEROL INCREASED 6 0.0001
732 COGNITIVE DISORDER 6 0.0001
733 APNOEA 1 0.0001
734 SWOLLEN TONGUE 4 0.0001
735 CHILLS 15 0.0001
736 DEHYDRATION 17 0.0001
737 DRY SKIN 17 0.0001
738 PRODUCT USE COMPLAINT 2 0.0001
739 OCULAR HYPERAEMIA 6 0.0001
740 RESPIRATORY TRACT CONGESTION 2 0.0001
741 PAIN IN EXTREMITY 37 0.0001
742 ABSCESS 2 0.0001
743 BLOOD PRESSURE FLUCTUATION 3 0.0001
744 DECREASED APPETITE 29 0.0001
745 ASTHMA 14 0.0001
746 MENTAL IMPAIRMENT 3 0.0001
747 MYALGIA 21 0.0001
748 FLATULENCE 7 0.0001
749 MUSCULAR WEAKNESS 14 0.0001
750 URINARY TRACT INFECTION 21 0.0001
751 VISUAL IMPAIRMENT 15 0.0001
752 DEVICE DIFFICULT TO USE 8 0.0001
753 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
754 MALAISE 53 0.0001
755 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
756 TREMOR 20 0.0001
757 EOSINOPHIL COUNT INCREASED 1 0.0001
758 POLLAKIURIA 5 0.0001
759 DRUG INEFFECTIVE 158 0.0001
760 GAIT INABILITY 4 0.0001
761 HOT FLUSH 9 0.0001
762 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
763 THERAPY CESSATION 6 0.0001
764 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
765 MUSCULOSKELETAL DISCOMFORT 2 0.0001
766 CARDIAC MURMUR 1 0.0001
767 DIPLOPIA 3 0.0001
768 SUICIDE ATTEMPT 7 0.0001
769 APPLICATION SITE ERYTHEMA 3 0.0001
770 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
771 PANCREATITIS 6 0.0001
772 DIARRHOEA 73 0.0001
773 HEAD DISCOMFORT 2 0.0001
774 INJECTION SITE HAEMORRHAGE 9 0.0001
775 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
776 ERYTHEMA 23 0.0001
777 FREQUENT BOWEL MOVEMENTS 3 0.0001
778 DEVELOPMENTAL DELAY 1 0.0001
779 PERIPHERAL SWELLING 17 0.0001
780 BONE DISORDER 2 0.0001
781 RESTLESSNESS 4 0.0001
782 TREATMENT FAILURE 9 0.0001
783 BREAST CANCER STAGE I 1 0.0001
784 CONJUNCTIVITIS 2 0.0001
785 FEELING COLD 3 0.0001
786 INFLUENZA 12 0.0001
787 BACTERIAL INFECTION 2 0.0001
788 APPENDICITIS 1 0.0001
789 HALLUCINATION 8 0.0001
790 BLOOD SODIUM DECREASED 2 0.0001
791 FOOT FRACTURE 2 0.0001
792 BLOOD URINE PRESENT 2 0.0001
793 INJECTION SITE ERYTHEMA 13 0.0001
794 INCREASED APPETITE 2 0.0001
795 MULTIPLE SCLEROSIS 5 0.0001
796 LETHARGY 6 0.0001
797 PYREXIA 36 0.0001
798 HERNIA 2 0.0001
799 ERUCTATION 2 0.0001
800 NEEDLE ISSUE 3 0.0001
801 MUSCULOSKELETAL STIFFNESS 9 0.0001
802 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
803 KIDNEY INFECTION 2 0.0001
804 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
805 CEREBROVASCULAR ACCIDENT 17 0.0001
806 CYTOKINE RELEASE SYNDROME 2 0.0001
807 PREMATURE BABY 3 0.0001
808 THERAPEUTIC RESPONSE DECREASED 6 0.0001
809 ADVERSE EVENT 9 0.0001
810 CHEST DISCOMFORT 10 0.0001
811 INJECTION SITE WARMTH 2 0.0001
812 COUGH 27 0.0001
813 NERVOUS SYSTEM DISORDER 3 0.0001
814 HALLUCINATION, VISUAL 2 0.0001
815 OSTEOARTHRITIS 4 0.0001
816 CYSTITIS 3 0.0001
817 EATING DISORDER 2 0.0001
818 ASTHENIA 35 0.0001
819 RHINORRHOEA 6 0.0001
820 DECREASED ACTIVITY 1 0.0001
821 RASH PRURITIC 5 0.0001
822 BLOOD GLUCOSE FLUCTUATION 1 0.0001
823 ANGIOEDEMA 4 0.0001
824 MEDICATION ERROR 5 0.0001
825 TRANSAMINASES INCREASED 2 0.0001
826 TOOTH DISORDER 2 0.0001
827 NECK PAIN 5 0.0001
828 GLOSSODYNIA 2 0.0001
829 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
830 SNEEZING 2 0.0001
831 THROAT IRRITATION 4 0.0001
832 BLISTER 5 0.0001
833 CHROMATURIA 2 0.0001
834 HEART RATE IRREGULAR 2 0.0001
835 HERPES ZOSTER 5 0.0001
836 MUSCLE TWITCHING 2 0.0001
837 ELECTROLYTE IMBALANCE 1 0.0001
838 CAESAREAN SECTION 1 0.0001
839 LOSS OF CONSCIOUSNESS 11 0.0001
840 BURNING SENSATION 6 0.0001
841 WHEEZING 5 0.0001
842 ATAXIA 1 0.0001
843 ARTHRALGIA 35 0.0001
844 CEREBRAL HAEMORRHAGE 3 0.0001
845 LOCALISED INFECTION 2 0.0001
846 STOMATITIS 5 0.0001
847 UNDERDOSE 6 0.0001
848 ACCIDENTAL OVERDOSE 3 0.0001
849 INJECTION SITE PAIN 25 0.0001
850 CARDIOMEGALY 1 0.0001
851 APPLICATION SITE IRRITATION 1 0.0001
852 HYPERTENSION 17 0.0001
853 AGEUSIA 2 0.0001
854 SYNCOPE 8 0.0001
855 DERMATITIS ALLERGIC 1 0.0001
856 CARDIOVASCULAR DISORDER 2 0.0001
857 DEVICE DEPLOYMENT ISSUE 1 0.0001
858 HYPOPHAGIA 2 0.0001
859 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
860 HOSPITALISATION 12 0.0001
861 ADVERSE DRUG REACTION 7 0.0001
862 DYSPNOEA 44 0.0001
863 RASH GENERALISED 2 0.0001
864 RESPIRATORY TRACT INFECTION 2 0.0001
865 SPEECH DISORDER 4 0.0001
866 GASTRITIS 2 0.0001
867 DRUG INTERACTION 12 0.0001
868 JOINT SWELLING 9 0.0001
869 BLOOD BILIRUBIN INCREASED 2 0.0001
870 PSORIATIC ARTHROPATHY 3 0.0001
871 PALLOR 2 0.0001
872 CONSTIPATION 16 0.0001
873 GAIT DISTURBANCE 14 0.0001
874 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
875 SKIN LESION 2 0.0001
876 APPLICATION SITE RASH 1 0.0001
877 DRUG INTOLERANCE 7 0.0001
878 ANAPHYLACTIC REACTION 4 0.0001
879 FALL 24 0.0001
880 BLOOD TEST ABNORMAL 1 0.0001
881 PAIN IN JAW 2 0.0001
882 AGITATION 5 0.0001
883 LABORATORY TEST ABNORMAL 2 0.0001
884 CARDIOMYOPATHY 1 0.0001
885 LIVER DISORDER 3 0.0001
886 PULMONARY OEDEMA 3 0.0001
887 GASTROINTESTINAL DISORDER 6 0.0001
888 BLOOD POTASSIUM DECREASED 2 0.0001
889 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
890 ECONOMIC PROBLEM 1 0.0001
891 OEDEMA PERIPHERAL 8 0.0001
892 TINNITUS 3 0.0001
893 ANKLE FRACTURE 1 0.0001
894 BASAL CELL CARCINOMA 1 0.0001
895 ARTHRITIS 5 0.0001
896 ANAEMIA 12 0.0001
897 BLOOD GLUCOSE DECREASED 3 0.0001
898 BLOOD POTASSIUM INCREASED 1 0.0001
899 DYSPEPSIA 6 0.0001
900 IMPAIRED HEALING 2 0.0001
901 NO ADVERSE EVENT 11 0.0001
902 DRUG LEVEL INCREASED 1 0.0001
903 VISUAL ACUITY REDUCED 2 0.0001
904 VIRAL INFECTION 2 0.0001
905 COAGULOPATHY 1 0.0001
906 URINARY RETENTION 2 0.0001
907 CELLULITIS 3 0.0001
908 GASTRIC DISORDER 2 0.0001
909 DEVICE DEFECTIVE 1 0.0001
910 DEVICE USE ERROR 2 0.0001
911 NERVOUSNESS 3 0.0001
912 MUSCULOSKELETAL PAIN 3 0.0001
913 DRUG WITHDRAWAL SYNDROME 5 0.0001
914 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
915 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
916 DRUG EFFECT DECREASED 3 0.0001
917 CONFUSIONAL STATE 9 0.0001
918 HAEMATOCHEZIA 3 0.0001
919 DYSURIA 2 0.0001
920 SEPSIS 6 0.0001
921 BREAST CANCER 5 0.0001
922 EPISTAXIS 4 0.0001
923 CARDIAC DISORDER 5 0.0001
924 OXYGEN SATURATION DECREASED 3 0.0001
925 DYSPNOEA EXERTIONAL 2 0.0001
926 COLITIS 2 0.0001
927 DYSPHAGIA 5 0.0001
928 DIABETES MELLITUS 4 0.0001
929 CHOLESTASIS 1 0.0001
930 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
931 CHOKING 1 0.0001
932 PLEURAL EFFUSION 3 0.0000
933 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
934 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
935 RECTAL HAEMORRHAGE 2 0.0000
936 HYPOACUSIS 2 0.0000
937 PNEUMONIA 15 0.0000
938 INFUSION RELATED REACTION 3 0.0000
939 THERAPY NON-RESPONDER 2 0.0000
940 HEPATIC ENZYME INCREASED 3 0.0000
941 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
942 DEVICE MALFUNCTION 3 0.0000
943 ARRHYTHMIA 2 0.0000
944 NEUROPATHY PERIPHERAL 4 0.0000
945 PRODUCTIVE COUGH 2 0.0000
946 DIABETIC KETOACIDOSIS 1 0.0000
947 HYPOGLYCAEMIA 2 0.0000
948 CEREBRAL INFARCTION 1 0.0000
949 LUNG DISORDER 2 0.0000
950 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
951 ANAPHYLACTIC SHOCK 1 0.0000
952 DEAFNESS 1 0.0000
953 BREAST CANCER FEMALE 1 0.0000
954 OEDEMA 2 0.0000
955 DIVERTICULITIS 1 0.0000
956 RHEUMATOID ARTHRITIS 4 0.0000
957 BONE PAIN 2 0.0000
958 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
959 ASCITES 1 0.0000
960 DISEASE PROGRESSION 4 0.0000
961 CATARACT 2 0.0000
962 HYPOTENSION 6 0.0000
963 DELIRIUM 1 0.0000
964 MOBILITY DECREASED 2 0.0000
965 C-REACTIVE PROTEIN INCREASED 1 0.0000
966 BLOOD GLUCOSE INCREASED 5 0.0000
967 DYSKINESIA 1 0.0000
968 BLINDNESS 1 0.0000
969 CARDIAC ARREST 2 0.0000
970 OVERDOSE 5 0.0000
971 RENAL FAILURE 3 0.0000
972 HAEMOGLOBIN DECREASED 2 0.0000
973 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
974 BRADYCARDIA 1 0.0000
975 DRUG DEPENDENCE 3 0.0000
976 DEPENDENCE 1 0.0000
977 ARTHROPATHY 1 0.0000
978 CONVULSION 1 0.0000
979 AMNESIA 1 0.0000
980 BLOOD CREATININE INCREASED 1 0.0000
981 CHRONIC KIDNEY DISEASE 1 0.0000
982 ACUTE KIDNEY INJURY 2 0.0000
983 CARDIAC FAILURE 1 0.0000
984 DRUG ABUSE 1 0.0000
985 TOXICITY TO VARIOUS AGENTS 2 0.0000
986 ATRIAL FIBRILLATION 1 0.0000
987 DEATH 4 0.0000